The company added LaFrance will continue to serve as its board chairman and succeeds Thomas McLain in the new roles.
Most recently, LaFrance has served as CEO of Omnyx, a joint venture of GE and UPMC in Pittsburgh.
Previously, LaFrance was employed with Ventana Medical Systems in global marketing and business development, as well as domestic and international commercial general management. In the past, he has led global marketing and business development for the Near Patient Testing division of Bayer Diagnostics.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia